Charles Schwab Insider Notice: 104,500 Shares to Be Sold on NYSE
Rhea-AI Filing Summary
The Charles Schwab Corporation Form 144 notifies a proposed public sale of 104,500 shares of common stock on the NYSE with an aggregate market value of $10,105,150 and an approximate sale date of 08/08/2025. The securities were acquired on 03/31/1987 in a leveraged buyout.
The filing also lists prior sales by Charles R. Schwab totaling 468,856 shares for gross proceeds of $40,864,082 on dates including 05/12/2025, 05/13/2025, 05/15/2025, 05/22/2025 and 08/07/2025. Total shares outstanding are stated as 1,816,970,383, making the proposed sale a very small fraction of outstanding shares. The signer affirms there is no undisclosed material adverse information and references Rule 10b5-1 plan language where applicable.
Positive
- None.
Negative
- Proposed sale of 104,500 shares with aggregate market value $10,105,150 to be sold on 08/08/2025 on the NYSE.
- Multiple recent insider sales totaling 468,856 shares for gross proceeds of $40,864,082 on dates including 05/12/2025, 05/13/2025, 05/15/2025, 05/22/2025 and 08/07/2025.
Insights
TL;DR Routine Form 144 filing showing modest proposed sale; recent insider sales produced substantial liquidity.
The filing documents a proposed sale of 104,500 shares (aggregate value $10,105,150) and reports prior disposals totaling 468,856 shares for $40,864,082 over the listed dates. Relative to the 1,816,970,383 shares outstanding, the proposed block is approximately 0.0058% of outstanding shares, so it is immaterial to company capitalization. The recent gross proceeds number is sizable in isolation but does not, by itself, convey company credit or operational impact because this is an individual insider sale disclosure.
TL;DR The filing appears procedurally complete and includes the required insider representations under Rule 144.
The notice includes acquisition details (acquired 03/31/1987 via a leveraged buyout), proposed sale timing (08/08/2025), and a standard representation that no undisclosed material adverse information exists. Multiple recent sales by the same person are disclosed with dates and gross proceeds, satisfying transparency obligations under the securities rules. Documentation references Rule 10b5-1 plan language where applicable, which is customary for planned insider dispositions.